IMNN: Imunon, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 13.12
Enterprise Value ($M) 7.25
Book Value ($M) 4.24
Book Value / Share 0.29
Price / Book 3.09
NCAV ($M) 2.54
NCAV / Share 0.17
Price / NCAV 5.17

Profitability (mra)
Return on Invested Capital (ROIC) -3.46
Return on Assets (ROA) -0.85
Return on Equity (ROE) -1.39

Liquidity (mrq)
Quick Ratio 1.67
Current Ratio 1.67

Balance Sheet (mrq) ($M)
Current Assets 8.01
Assets 9.72
Liabilities 5.47
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -19.13
Net Income -18.62
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -18.85
Cash from Investing 9.83
Cash from Financing 9.06

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-13 13G/A Ayrton Capital LLC 7.90
11-14 13G/A CVI Investments, Inc. 4.90 -37.57

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-10 10,072 35,806 28.13
2025-03-07 15,943 34,918 45.66
2025-03-06 8,460 21,715 38.96
2025-03-05 12,564 25,166 49.92

(click for more detail)

Similar Companies
IMCC – IM Cannabis Corp. IMMX – Immix Biopharma, Inc.
IMNM – Immunome, Inc. IMTX – Immatics N.V.
INAB – IN8bio, Inc.


Financial data and stock pages provided by
Fintel.io